1. Home
  2. EIG vs ARDX Comparison

EIG vs ARDX Comparison

Compare EIG & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • ARDX
  • Stock Information
  • Founded
  • EIG 2000
  • ARDX 2007
  • Country
  • EIG United States
  • ARDX United States
  • Employees
  • EIG N/A
  • ARDX N/A
  • Industry
  • EIG Property-Casualty Insurers
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EIG Finance
  • ARDX Health Care
  • Exchange
  • EIG Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • EIG 986.1M
  • ARDX 882.9M
  • IPO Year
  • EIG 2007
  • ARDX 2014
  • Fundamental
  • Price
  • EIG $40.01
  • ARDX $5.93
  • Analyst Decision
  • EIG
  • ARDX Strong Buy
  • Analyst Count
  • EIG 0
  • ARDX 10
  • Target Price
  • EIG N/A
  • ARDX $10.65
  • AVG Volume (30 Days)
  • EIG 256.6K
  • ARDX 4.2M
  • Earning Date
  • EIG 10-30-2025
  • ARDX 10-30-2025
  • Dividend Yield
  • EIG 3.23%
  • ARDX N/A
  • EPS Growth
  • EIG N/A
  • ARDX N/A
  • EPS
  • EIG 2.58
  • ARDX N/A
  • Revenue
  • EIG $904,800,000.00
  • ARDX $398,234,000.00
  • Revenue This Year
  • EIG $2.62
  • ARDX $18.90
  • Revenue Next Year
  • EIG N/A
  • ARDX $31.52
  • P/E Ratio
  • EIG $15.36
  • ARDX N/A
  • Revenue Growth
  • EIG 1.69
  • ARDX 58.12
  • 52 Week Low
  • EIG $35.73
  • ARDX $3.21
  • 52 Week High
  • EIG $54.19
  • ARDX $6.78
  • Technical
  • Relative Strength Index (RSI)
  • EIG 52.59
  • ARDX 57.62
  • Support Level
  • EIG $38.42
  • ARDX $5.30
  • Resistance Level
  • EIG $39.88
  • ARDX $5.99
  • Average True Range (ATR)
  • EIG 0.73
  • ARDX 0.29
  • MACD
  • EIG 0.23
  • ARDX -0.01
  • Stochastic Oscillator
  • EIG 96.42
  • ARDX 66.32

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: